INTRODUCTION
Lipid raft are membrane microdomains characterized by a particular lipid composition, consistent in high levels of cholesterol, sphingolipids and saturated fatty acids that enable a particular structural order and membrane packing. This microenvironment facilitates the compartmentalization of particular subsets of lipid and proteins, interacting in highly dynamic signaling platforms (or signalosomes) that are essential for a plethora of physiological functions [1, 2] . In particular in the brain, these microdomains play a key role in neuronal development, synapsis, axonal growth, exo/endocytosis and survival [3] [4] [5] [6] . Recent data have demonstrated that alterations in the molecular composition of lipid rafts are associated with different neurodegenerative processes related to different pathologies, such as Alzheimer's disease (AD), Parkinson's disease (PD), Prion diseases, Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) [7] [8] [9] .
Thus, the main proteins responsible for amyloidogenesis, amyloid precursor protein (APP), -secretase (BACE1) and presenilin-1 (PSEN1) are present, at least transiently, in these microdomains [10] [11] [12] . Moreover, Aformation and aggregation is enhanced in lipid rafts [13] . Other neuropathological protein markers, such as -Synuclein (-Syn) related to PD and other synucleopathies, and prion protein (PrPc) have also been found to be integrated into these microdomains [14, 15] . These findings are indicative of the importance of lipid rafts in pathological processes associated with toxic protein aggregation and neurodegeneration. Another interesting feature of raft microstructures is that they are the preferential site of numerous signaling proteins clustered in signaling platforms or signalosomes that trigger and/or regulate numerous physiological activities in the brain [16, 17] . Considering the importance of lipid-protein interactions and dynamics in these microstructures, it is plausible that alterations in the stability and homeostasis of lipid rafts may be a crucial aspect for progressive neurodegeneration. In this sense, alterations in the physicochemical properties of lipid rafts have been associated with modifications in lipid matrix composition that occurs with the progression of, both, AD and PD [18, 19] . These changes affect, among others, the membrane order, domain packing and compressibility, F o r R e v i e w O n l y lateral movements, phase segregation, viscosity [20, 21] and, consequently, may constraint the proper interaction of raftintegrated proteins [22] . In line with this, it should be emphasized that physiological brain aging is also accompanied by a progressive modification in the molecular composition and structure of lipid rafts (coined as "lipid raft aging"), but this normal biological process appears to be accelerated during the development of brain neurodegenerative events [23] . Interestingly, increasing data indicate that alterations in these microstructures may be early-onset events of age-related neuropathologies, such as Alzheimer's disease (AD) and Parkinson's disease (PD). Noticeably, raft lipid matrix is altered at early stages of AD and incidental PD, observing an alteration of raft physicochemical properties that curses with an increase in viscosity and membrane order as a result of a reduction in, both, cholesterol and long-chain polyunsaturated fatty acid (LCPUFA) content [19, 24] . Indeed, these alterations are correlated with an enhancement of A processing [24] , and interactions with raft protein markers related to extrinsic apoptosis [25] . In this order of ideas, early alterations in raft microdomains may be used as predictors of further development of these aged-related diseases, as reflected in cerebrospinal fluids [26] .
These relevant findings will be discussed throughout this review.
LIPID RAFT MICRODOMAINS AS DYNAMIC MICROSTRUCTURES.
Lipid rafts have been traditionally described as plasma membrane microdomains enriched in cholesterol and sphingomyelin which confers a high resistance to solubilization by non-ionic detergents at low temperatures [27, 28] . The concept of lipid raft has progressively evolved towards sterol-and sphingolipid-enriched dynamic nanoscale assemblies of particular lipid classes and integrated proteins that can fluctuate and be reorganized depending on extracellular stimuli. Therefore, they are presently considered signaling platforms (signalosomes) where numerous signal transduction events and membrane trafficking occur [2] . This configuration confers peculiar biophysical properties, consisting in a higher liquid ordered state that phase segregates within the two layers of plasma membrane [1] . Furthermore, lipid rafts are the preferential site for the localization of different proteins that participate in numerous intracellular signaling processes [22] . These proteins constitute dynamic assemblies of lipid-protein and protein-protein oligomers that stimulate raft configuration and functionality. Many raft-integrated proteins are anchored to specific lipid moieties present in these microstructures, such as glycosylphosphatidylionositol (GPI), or are modified by palmitoylation or myristoylation to allow their attachment to lipid rafts. In this sense, numerous GPI-anchored proteins participate in signal transduction pathways [29] , and palmitoylation of different proteins has been involved in the activation of several raft-localized kinases involved in neuronal maintenance [30, 31] .
Other strategies developed by proteins to be integrated into lipid rafts are through their binding to raft-scaffolding proteins, such as caveolin-1 and flotillin-1. These raft protein markers not only provide stabilization of the microstructure but also contribute to compartmentalization of signaling molecules to modulate cell signaling in numerous events, including neuroprotective and neurotrophic pathways [32] [33] [34] [35] . Interestingly, recent work has proposed a role for prion protein (PrPc) as an additional scaffolding protein in signalosomes where it selectively interacts with different membrane signaling proteins with physiological relevance in cellular communication and synapses [36, 37] .
Overall, the significance of lipid/protein signaling association in lipid rafts evokes the importance of these clusters for the local assembly of different modulators of neuronal processes in response to extracellular or intracellular signals involved in synaptic function, cell adhesion, plasticity, neurotrophism, axon growth and guidance, and exo/endocytosis [3, 4, 6, 38] .
Beyond their role in the normal physiology of nerve cells, increasing data has also revealed the importance of lipid rafts in neurodegenerative processes related to Alzheimer's disease, Parkinson disease, Prion diseases, Huntington's disease, and amyotrophic lateral sclerosis [7] [8] [9] 39] . Thus, an increasing body of evidence has demonstrated that these microdomains have a crucial role in amyloid production, which aggregate forming senile plaques, through stimulation of the amyloidogenic processing of the amyloid precursor protein (APP, 13, 16, 40] . APP is represented in, both, lipid raft and non-raft fractions, although S-palmitoylation of the protein promotes targeting into raft domains [41] . Indeed, the other two main components of A formation, BACE and -secretase, also undergo S-palmitoylation enhancing their presence in lipid rafts [16, 42] . Interestingly, BACE has been shown to be accumulated in lipid raft of human cortical areas with the progression of Alzheimer's disease, in parallel with an increase in the interaction with APP [24] . This phenomenon is particularly relevant as APP/BACE interaction in lipid rafts may facilitate the initial cleavage stage in the amyloidogenic processing of APP to render A, therefore reinforcing the importance of protein clustering in these membrane microstructures for the neuropathological process occurring in AD [43] [44] [45] .
Furthermore, different proteins involved in PD pathology have been reported to associate or interact with lipid rafts, suggesting that molecular partitioning within lipid raft is also relevant in this neuropathology. α-synuclein (α-Syn), the main pathological hallmark of PD that accumulates in intraneuronal Lewy bodies [46] , is also found located in these microdomains, where it apparently has a role in synaptic processes [14] . In lipid rafts, this protein binds to particular phospholipids (with a preference for phosphatidylserine) and fatty acids (oleic acid and LCPUFA) [47, 48] . However, as demonstrated in different membrane models, -Syn also appears to alter the lipid stability of neuronal membrane microdomains [49] , where it modulates neurotransmitter release mediated by Cav2.2 channel [50] . Other PD-related proteins associated with lipid rafts are Parkin [51] , PINK1 [52] , DJ-1 [53] and LRRK2 [54, 55] . In addition, lipid rafts are also involved in molecular mechanisms related to mutant huntingtin [56, 57] , and Prion protein [15, 58] . Overall, these observations imply that lipid rafts are pivotal in neurodegenerative diseases associated with aging and protein aggregation. Accordingly, functional alteration of neuronal rafts may be a common event in these pathologies. These alterations may be triggered by derangements of raft lipid matrix as discussed below.
LIPID RAFT STABILITY AND PROGRESSIVE NEURODEGENERATION.
The brain contains the higher amount of different lipid species of the whole organism [59] , and possesses a complex and unique lipidome. Indeed, neurolipidomics is an emerging and challenging field whose interpretation may contribute to unveil numerous neuropathological events [60, 61] . Of particular interest is docosahexaenoic acid [DHA; 22:6(n-3)] the most abundant n-3 LCPUFA, which is especially enriched in membrane phospholipids of neural tissues [62, 63] , participates in multiple mechanisms that contribute to neuroprotection, but also appear to be severely altered in different neurodegenerative diseases [64, 65] .
A significant body of data has demonstrated the involvement of lipid modifications in the brain related to AD progression [66] [67] [68] . Moreover, considering the importance of lipid raft microenvironments in brain maintenance, it is conceivable that aberrant alterations in raft lipid classes distribution and proportions may induce metabolic disturbances and dysfunctioning [69] . In agreement with this, changes in lipid composition in cortical areas of lipid rafts represent a common observation in different neuropathologies, such as Alzheimer and Parkinson [70] . Previous analyses of lipid rafts from frontal cortex of AD brains at late stages (V/VI, [71] ) showed a poor content of LCPUFA, especially DHA. In these samples, DHA contents were reduced by around 30%, as compared with healthy agematched controls [18] . In contrast, AD V/VI lipid rafts did not revealed differences in the amount of cholesterol and sphingomyelin, and phospholipids, suggesting that n-3 LCPUFA is the main responsible of the observed alterations in these microstructures at late stages of AD [18, 72] . These data are relevant since it actualizes the classical dogma associating cholesterol reduction in neuronal membranes and AD pathogenesis [73, 74] , demonstrating that other lipid classes may also play an important role [40, 75] .
Furthermore, relevant data has revealed that profound changes in lipid composition are already detected in lipid rafts of human cortical areas at early asymptomatic and prodromal AD (stages I/II and III/IV) [24] before the appearance of senile plaques and neurofibrillary tangles, suggesting that lipid changes may precede these pathological events. Alterations in raft lipid matrix in early stages of AD were of higher magnitude than those of ADV/VI, detecting a significant reduction in the levels of cholesterol, sphingomyelin and arachidonic acid (n-6 LCPUFA; 20:4(n-6)]). This phenomenon may be explained by the high degree of metabolic stress and homeostatic disruption of these microstructures [76] [77] [78] , which may not be mechanistically counteracted in advanced AD stages [79] . Homologous lipidomic findings have been reported using a double transgenic APP/presenilin 1 mouse, a familial model of AD neuropathology. In raft fractions from the neurocortex of these animals, a progressive decrease in cholesterol, sterol ester levels and LCPUFA was observed, which correlated with an increase in saturated fatty acid and sphingomyelin content, and phospholipids/cholesterol ratio [23] . These alterations were exacerbated in aged transgenic mice as compared with wild type controls, suggesting a correlation between aged cortical neuronal lipid raft detriment and AD phenotype. Alterations in the contents of long-chain ceramides and cholesterol have also been observed in another transgenic mouse model of AD (APP SL /PS1Ki), in correlation with similar results obtained in human AD cortex [80, 81] .
Furthermore, reduction of LCPUFA was particularly significant in lipid rafts as compared with whole membranes, indicating a differential deacylation-reacylation of these fatty acids induced by AD-related pathology [23] . In line with this, dietary fish oil supplementation in APP/PS1 mice has been shown to reduce A processing and production, but not accumulation, in parallel with a reduction of cognitive deficits in these mice [82] . Also, in 5xFAD transgenic mice, administration of a DHA derivative (OHDHA) was observed to reduce A load, in correlation with a reduction in A binding into OHDHA-enriched lipidraft-like vesicles [83] .
Apart from AD, lipid rafts of PD brains have also been reported to exhibit aberrant composition with the progression of this disease. Noticeably, the alterations were similarly observed in cortical areas of these patients, in conjunction with previous observations of early cortical dysfunction and memory deficit before than motor symptoms occur [84, 85] . Thus, in lipid raft fractions from these patients, both, frontal and entorhinal cortices were enriched in sphingomyelin, cholesterol and saturated fatty acids, as compared to agematched controls. Interestingly, in line with the "lipid raft aging" concept [23] , a similar degree of raft lipid matrix perturbation was detected in incidental Parkinson disease (iPD), before Parkinsonism symptoms arise [84, 86, 87] . In this sense, lipid rafts from frontal cortex of either iPD or PD cases, were dramatically modified in their contents of n-3 (mainly DHA) and n-6 LCPUFA (especially arachidonic acid, 20:4n-6), whereas the contents of sphingolipids and cholesterol remained unaltered [19] . These results indicate that phospholipid metabolism deregulation occurs from early stages of this disease. It is noticeable that misfolding and aggregation of -Syn, a key causal of PD progression, has been shown to induce lipid peroxidation in neurons [88] , which might explain the reduction of n-3 and n-6 LCPUFA. Also, -Syn monomers oligomerize upon interaction with LCPUFAs [89] , thereby potentially aggravating a vicious circle of pathological progression. Indeed, oxidative damage and lipid peroxidation are considered key factors of PD pathogenesis [90] [91] [92] . However, a peculiar finding in PD frontal cortex is that the reduction of n-3 and n-6 LCPUFA levels appears to be restricted to raft microstructures, since the proportion of both LCPUFA were found significantly increased in total membranes extracted from this brain area [92, 93] . These data indicate that oxidative damage of cortical neurons may not be the only factor driving the neurodegenerative process [19, 94, 95] . Consistently, we have recently observed that MPTP-treated mice, a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 F o r R e v i e w O n l y toxicological mouse model of PD, increases their n-3 LCPUFA (DHA) contents in the frontal cortex compared to wild-type animals, while the brain area containing the basal ganglia undergo a clear decline in its DHA contents in response to the neurotoxin, in an age-dependent manner (unpublished results). Thus, it seems that the fate of changes in n-3 LCPUFA nerve membrane contents in PD vary depending on brain area and the membrane microdomain considered [19, 93] .
A relevant consequence of lipid matrix impairment in neuronal membrane microstructures is the reduction in the unsaturation and peroxidability indexes in raft microenvironments, which likely impact their structural properties, such as raft size, physical order, lateral segregation, elastic compressibility, and molecular clustering [96, 97] . These aberrant modifications have been postulated as a crucial episode in neuronal degeneration, as changes in raft biophysical parameters appear to affect lipid-protein interactions and their activities [98] .
Recent biophysical studies in lipid raft alterations associated with AD pathology have demonstrated that, in parallel with changes in the lipid matrix, there is also an enhancement of viscosity and molecular order as compared with raft microdomains from subjects without apparent lesions [18] . This phenomenon may be due in part to the progression of lipid changes in the composition of lipid rafts even at the earliest stages of the disease. In particular, alteration in cholesterol and n-3 LCPUFA (and to a lesser extent n-6 LCPUFA) has been detected in early stages of, both, AD and PD. It is known that these lipids show uneven distribution into membrane leaflets, with cholesterol preferentially located in the outer leaflet whereas DHA (and AA) is enriched in the inner leaflet [99] [100] [101] . Consequently, aberrant rearrangements of these essential lipid species may affect lateral phase separation in lipid raft microdomains [66, 69, 96, 102] . In this order of ideas, steady-state fluorescence anisotropy analyses of lipid rafts have been performed to evaluate neuronal raft membrane viscosity and lateral mobility using two distinct lipophilic fluorescent probes that integrate either at the membrane hydrophilic interface plane (to assess lateral displacements) or at the hydrophobic core (to evaluate the behavior of the internal microenvironment) [20, 21, [103] [104] [105] . The results indicate that AD lipid rafts from cortical areas have demonstrated that depletion of cholesterol and n-3/n-6 LCPUFA species, in parallel with accumulation of saturated fatty acids, resulted in increased order and viscosity and, consequently, abnormally packed membranes [21, 44] . In line with this, similar results have been reported in lipid rafts from aged APP/PS1 transgenic mice (as a model of familial AD), observing an increased in raft viscosity as a result of the reduction in the amount of, both, cholesterol and DHA [20] . A further link between microstructure lipid destabilization and AD pathogenic events have been recently reported in lipid rafts from frontal and entorhinal cortices at early stages of AD, where the amount and degree of association between APP and BACE into lipid rafts was found to be highly correlated with raft microviscosity [21] . Enhancement in the interaction of these proteins in neuronal lipid rafts may promote A formation [16, 43, 44] , even while no senile plaques are detectable in these regions at very early stages of AD [106, 107] . Overall, these data suggest that changes in raft lipid biochemistry may result in complex deregulation of their physicochemical microenvironment, as an outbreak of pathological events related to AD which are accelerated during aging [23] . Finally, as mentioned before, equivalent alterations in polyunsaturated fatty acids and unsaturation index have been demonstrated in brain cortex lipid raft from PD and incidental PD [19] , therefore, it can be envisaged that similar modifications in the biophysical properties of these microstructures might also occur early in PD, eventually increasing the severity of this disease [19] . This hypothesis remains to be confirmed.
ALTERATION IN RAFT PROTEIN DYNAMICS ASSOCIATED WITH NEUROPATHOLOGIES.
Emerging data reveal that the pathophysiological consequences of structural alterations in lipid rafts, in particular in early stages of AD and PD, have important consequences on the dynamics of signaling platforms (signalosomes) integrated in these microstructures [16, 17, 108] . These alterations may induce physiological impairment as a consequence of aberrant protein aggregation, interactions and multiprotein complex formation, and toxic intracellular signaling.
Lipid raft components may act as catalyzers of amyloidogenesis through the interaction with gangliosides, sterols and phospholipids [109] , that enhances the assemblies of amyloid oligomers in -sheets leading to the formation of membrane pores [110, 111] . Thus, a plausible scenario is that interaction of amyloid structural configurations with membrane raft lipid components may trigger profound destabilization of the structure, thereby promoting amyloid toxicity.
Apart from the involvement of lipid rafts in the mechanistic biophysical events to trigger A aggregation, APP processing may also occur in lipid rafts. It has been demonstrated that APP palmitoylation induces its translocation into lipid rafts, where clustering with flotillin 1 regulates amyloid generation [41, 112] . Moreover, BACE and-secretase appear to modulate A release through binding to lipids located in these microstructures [10, [113] [114] [115] . These results indicate that lipid rafts may actively participate in the dynamic of A production and aggregation to induce neurotoxicity. Thus, it is plausible that lipid raft impairment may be involved in protein signaling events leading to AD progression. In this order of ideas, recent data has demonstrated that lipid rafts extracted from cortical areas of ADI/II and ADIII/IV show an increase in the trafficking of BACE into raft fractions, thereby showing a high interaction with APP [24] . This observation appears to be specific of BACE, since PSEN1, a component of -secretase complex, remained invariable in these AD rafts [24] . Also, this phenomenon was specific of cortical areas at early stages of the pathology, as cerebellar lipid rafts extracted from these same subjects did not reproduce these results. Interestingly, APP/BACE convergence in lipid rafts as a consequence of AD was correlated with an increase in the microviscosity and molecular order of these microstructures [21] . This strengthens the fact that the physicochemical state and nanoscopic dynamics of lipid rafts, influenced by alterations in membrane trafficking, is crucial in amyloidogenesis and AD pathology [44, 116] .
Furthermore, other proteins involved in neuropathological events have been found in association with APP within lipid rafts. This is the case of VDAC (voltage-dependent anion channel), a mitochondrial-related porin associated to the plasma membrane, which plays different roles associated to cell death, including extrinsic apoptosis, ATP efflux, cell exhaustion but also in the mechanism of A toxicity [77, [117] [118] [119] [120] . Recent data has demonstrated that the porin interacts with, both, APP and A in raft microdomains, where it might be involved in the mechanisms of A-related toxicity [25] . In this sense, it appears that VDAC/A interaction induces the activation of intracellular tyrosine phosphatases that dephosphorylate the channel, and may promote its gating. Furthermore, VDAC has also been found dephosphorylated in lipid rafts from cortical areas of AD brains at ADI/II and ADIII/IV stages, indicating that dephosphorylation of the channel promoted by A may be related to neurotoxicity [25] . In support of this, Down syndrome patients, known to develop anatomopathological parameters similar to AD, exhibit similar VDAC dephosphorylation pattern in different brain cortices [121] . The importance of this channel in amyloid processing is also supported by additional work showing the interaction of VDAC with -secretase, and also that gene silencing of this channel reduces A peptide production in around 70% [11] . These data indicate that protein clustering in lipid rafts associated with A production and accumulation may activate toxic intracellular signaling leading to neuronal impairment.
Promotion of toxic protein aggregation in lipid rafts may be extended to other diseases, where a similar correlation with lipid matrix impairment has been reported. PrPc is another lipid raft integrated protein through its anchoring to glycosylphosphatidylinositol (GPI), a phenomenon that has important implications in PrP sorting and prion disease development [58, 122] . Thus, aberrant misfolding of PrPc, leading to accumulation of pathological PrPsc, takes place in lipid rafts [9] . PrPc has also been proposed as a receptor of A aggregates [123] , suggesting that this protein may act as an additional scaffolding molecule that promotes local protein assembly in signaling platforms [124] . Moreover, this protein aggregation is affected by alterations in lipid homeostasis, in particular associated with the decrease in cholesterol content, demonstrating a reciprocal correlation between prion neurotoxicity and lipid metabolism impairment [9, 125] .
Another crucial aspect of lipid raft preservation is related to the dynamics of -Syn related to PD pathology. This protein is highly abundant in intraneuronal inclusions named Lewy bodies, a pathological marker of PD. -Syn binds to lipid rafts with the requirement of a particular combination of lipid classes and particular acidic phospholipids [14, 47, 48] , and it is recruited into these domains through its binding to GPI in presynaptic membranes [126] . Lipid binding of -Syn has been observed to induce a change in its configuration to alpha-helicity [127] , a common motif of lipid-binding proteins [128] . Moreover, -Syn production is associated with high levels of sphingomyelin, a main feature of lipid rafts [129] . Conversely, this protein has been shown to modulate brain lipid metabolism [130, 131] . In this order of ideas, recent experiments performed by our group has demonstrated that -Syn shows a different lipid raft content in a PD model of neurotoxicity, observing a trafficking out of the raft in response to the injury in an age-related manner (unpublished results). Overall, these findings provide new evidence related to the importance of raft lipid homeostasis related to -Syn pathology in PD.
Further work will be required to better characterize the significant alterations of multiprotein complexes in lipid rafts that may correlate with neuropathological events involving lipid matrix disarrangement.
LIPID RAFT CONSTITUENTS AS PREDICTORS OF NEUROPATHOLOGICAL DISEASES. A POTENTIAL DIAGNOSTIC STRATEGY.
AD and PD have a high prevalence which is progressively increasing with the population ageing [132, 133] . Treatment of these devastating diseases requires early intervention in order to obtain treatment's effectiveness, since a high irreversible degree of brain deterioration is observed at late stages. Although important efforts have been made in the search of accurate diagnosis, there is still a lack of diagnostic tools in preclinical AD and PD. Therefore, a major challenge is the search of novel biomarkers useful for prognosis and disease progression, in the aim of identifying at-risk individuals for dementia. In this sense, early detection of lipid raft impairment may be a novel strategic approach [26] .
Lipid raft components have been detected in microvesicles and exosomes [134] , which are small vesicles (30-120 nm) containing nucleic acid and proteins secreted to the extracellular space [135, 136] . It has been suggested that regulation of secretion and intake of these membrane microvesicles may occur in combination with raft domains. In agreement with this, some recent data has revealed that caveolin 1 raft scaffolding protein participates in the regulation of exosomes uptake in a lipid-raft dependent mechanism of endocytosis [137] . The role of extracellular vesicles has been related to cell signaling and removal of misfolded molecules [138] . These microvesicle bodies have been claimed as vehicles for the release of different protein markers related to AD, PD and prion diseases [139] and, therefore, have been proposed as biomarkers for clinical diagnosis [140] .
As discussed before, numerous alterations in the amount, trafficking and interaction of proteins integrated in lipid rafts has been associated with neurodegenerative disorders [16, 17] . Since important changes in raft protein complexes formation and dynamics are detected in asymptomatic stages of, both, AD and PD, this suggests that perturbations of lipid raft molecular machinery may form part of etiopathological events. In support of this hypothesis, some results have demonstrated that exosomes participate in APP processing, prion protein trafficking, and spreading of phosphorylated Tau and -Syn [141] [142] [143] . In addition, lipid components characteristic of lipid raft structures, i.e. cholesterol, sphingomyelin and gangliosides, have also been found highly represented in exosomes [144, 145] . Furthermore, a role of lipid rafts in sorting proteins into exosomes has been demonstrated and it appears that some molecules are released in the extracellular medium via their association with lipid raft domains of the exosomal membrane [134] .
As previously discussed, some lipid classes and protein components of lipid rafts have been observed to be profoundly altered before the arousal of neuropathological symptoms in cortical brain areas. Therefore, we hypothesized that detection of these potential raft alterations may constitute an interesting strategy for accurate early biomarkers of these diseases. In support of this, extracellular vesicles containing raft material are found in cerebrospinal fluid (CSF), and also in peripheral fluids, such as urine and serum [146, 147] .
Amongst them, detection of lipoperoxidation and oxidative damage-associated metabolites, and enzymes involved in lipid degradation (such as sphingomyelinases and phospholipases) may be assessed. In this sense, a plausible quantification of oxidative and lipoperoxidative products, as well as antioxidant buffering capacity may be performed in CSF [148] . In agreement with this, phospholipase 2 (PLA2) activities appears increased in CSF at late onset of AD [149] . Moreover, decreased levels of free phospholipids (in particular phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine) have been detected in AD fluids, together with the enrichment of phosphatidylethanolamine and phosphatidylserine fractions in LCPUFA with the progression of the neurodegeneration [149] . Also, increased levels in F(2)-isoprostanes (which derive from oxidative damage of LCPUFA) in CSF have been observed in individuals with advanced age and especially in AD, as an indicative of free radical injury enhancement [150] .
Furthermore, some proteins accumulated in raft fractions may be candidates as CSF biomarkers. Thus, CSF levels of raft scaffolding proteins, flotillin 1 and caveolin 1, may also vary as a consequence of the AD neuropathology. Flotillin 1 is also characterized as an exosomal protein marker present in human CSF [151] . Particularly promising is CSF detection of aberrant assemblies of raft-related proteins as a mirror of neurotoxic anomalies occurring in the cortex before pathological symptoms, which may be an indicator of the degree of neurodegeneration [152] . Modifications in the posttransductional pattern of some raft integrated proteins may serve to determine early alterations in these microstructures at the peripheral level. As an example, VDAC dephosphorylation in lipid rafts is correlated with A association and AD progression [25] , and protein Snitrosylation and carbonylation has been attributed to protein misfolding and neuronal injury [153] [154] [155] . Furthermore, BACE1 expression has been shown to be dually regulated by S-nitrosative and oxidative stress [156] . Further, Snitrosylation, S-glutathionylation and oxidative signals also appear to participate in -Syn secretion, synaptic transmission impairment and PD progression [155] .
Overall, it is plausible that future biomarkers at the onset of the AD and PD neuropathologies may consist of multivariate determination and analyses of lipid and protein markers of lipid rafts and other membrane nanoscale structures that may alter their interplay as a result of early events in the development of these diseases.
CONCLUSION
Lipid rafts play a key role in signaling activities associated with neuronal functioning. Also, they provide the scenario where numerous events occur as a prelude of neuronal impairment, in particular, related to age-related diseases, such as AD and PD. Since normal aging induces subtle changes in raft lipid matrix composition, this process is exacerbated with neuropathology progression, where important alterations in lipid and protein dynamics occur. Furthermore, aberrant structural domains at early stages of neuropathology may progressively induce dramatic perturbations in lipid/protein molecular clusters integrated in these microenvironments, thereby promoting toxic signaling and pathology-related associations (see Fig. 1 for a schematic representation). A better characterization of the mechanisms related to lipid raft impairment and their correlation with early-onset events in these neurodegenerative diseases may provide a potential source of novel biomarkers for neurological conditions.
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